FDA Warning Letter — Bioiberica, SAU
The FDA took a Warning Letter action against Bioiberica, SAU on June 30, 2022 (Palafolls, Spain). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Bioiberica, SAU
- Date
- June 30, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Palafolls (Spain)